First Trust Nasdaq Pharmaceuticals ETF FTXH
Set alert
44.23 USD +0.37 +0.84%
As of Nov 3, 10:17 AM ET
43.91 Day range 44.28
29.86 52-week range 44.78
- YTD
- +34.27%
- 1 year
- +47.43%
- Open
- 43.91
- Prev close
- 43.86
- Mkt cap
- 1.18B
- Vol
- 10.09K
- Avg vol
- 178.29K
- EPS
- 1.59
- P/E
- 27.75
- Div yield
- 0.00%
More statistics
- Low
- 43.91
- High
- 44.28
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 41.68
- 200-d avg
- 37.19
6M chart
Events in this range
- Jun 25, 2026Dividend: 0.092
- Sep 24, 2026Dividend: 0.0113
Signals (34)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| RSI: Overbought | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | Jun 26, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| SMA: Bullish | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
Newest 20 of 34.
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 27.54
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 41.68
- 200-day average
- 37.19
About First Trust Nasdaq Pharmaceuticals ETF
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
News
- Is First Trust NASDAQ Pharmaceuticals ETF (FTXH) a Strong ETF Right Now?
- Should You Invest in the First Trust NASDAQ Pharmaceuticals ETF (FTXH)?
- Why Is Eli Lilly Stock Falling Tuesday?
- Is First Trust NASDAQ Pharmaceuticals ETF (FTXH) a Strong ETF Right Now?
- Should You Invest in the First Trust NASDAQ Pharmaceuticals ETF (FTXH)?
- Trump to announce discount drug pricing expansion, White House official says
- Could pressure to make money faster kill the next lifesaving pill?
- What's Going On With Bristol-Myers Squibb Stock Today?
- Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
- Pharma ETF (FTXH) Hits New 52-Week High
Your note
Sign in to keep a note on FTXH — it syncs with the Stock Master app.